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Proton NMR spectroscopy of synthetic peptides corresponding to defined regions of human dystrophin has been employed to study the interaction 
with F-actin. No evidence of interaction with a C-terminal region corresponding to amino acid residues 34293440 was obtained. F-actin restricted 
the mobility of residues 19-27 in a synthetic peptide corresponding to residues 10-32. This suggests that this is a site of F-actin interaction in 
the intact dystrophin molecule. Identical sequences to that of residues 19-22 in dystrophin, namely Lys-Thr-Phe-Thr are also present in the N- 
terminal regions of the a-actinins implying this is also a site of F-actin interaction with a-actinin. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
The recent work of the Kunkel [l] and Worton [2] 
groups has established that dystrophin, a protein of 
predicted molecular weight 427000, is absent or in 
some cases present in modified form in patients with 
Duchenne and Becker muscular dystrophies (Xp21 
myopathies). Study of the amino acid sequence of 
dystrophin suggests that four domains can be 
distinguished in the molecule [3]. These are the N- 
terminal region possessing homologies with a-actinin, a 
long run of triple helical segments resembling spectrin, 
a cysteine-rich sequence and a C-terminal domain. 
Although it has been presumed from the homologies 
with cr-actinin that actin interacts with the N-terminal 
domain of dystrophin, direct evidence of this has not 
yet been reported. Proton NMR spectroscopy applied 
to defined protein and peptide sequences is a powerful 
tool for the investigation of protein interactions, as we 
have demonstrated in earlier studies on the interaction 
of actin with troponin I [4] and caldesmon [5]. By ex- 
tending this approach to dystrophin, we have identified 
one site on this protein that is involved in interaction 
with actin. Our observations provide insight into the 
functional aspects of the N-terminal region of 
dystrophin, a region shown to be retained in the 
shortened form of the molecule found in patients with 
mild forms of Xp21 myopathy [6]. 
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Peptides were synthesized by Alta Bioscience, Birmingham Univer- 
sity using Fmoc polyamide chemistry, purified by HPLC and finally 
treated with glacial acetic acid for 2 h at 18°C to remove traces of 
blocking agents. Acetic acid was removed by freeze-drying followed 
by repeated issolution in water and freeze-drying. Actin from rabbit 
skeletal muscle was prepared as described previously [4]. Samples 
were dissolved in DzO and proton NMR spectroscopy was carried out 
on a Briiker 500 MHZ instrument operated under the auspices of the 
Oxford Centre for Molecular Sciences. Titrations with actin were car- 
ried out by the addition of small aliquots of a stock solution (200 FM) 
containing 0.5 mM DTT. Two dimensional COSY experiments were 
carried out as previously described [7]. 
3. RESULTS AND DISCUSSION 
In our initial studies, the possible interaction of actin 
with two synthetic peptides, namely those correspon- 
ding to residues l-32 and 3429-3440 of human 
dystrophin, was investigated. The C-terminal peptide 
was readily soluble, but on addition of F-actin up to a 
2 : 1 molar excess to a solution containing 0.4 mM pep- 
tide in 0.5 mM DTT, 10 mM sodium bicarbonate, pH 
7.0, the spectra obtained corresponded to the sums of 
the components. Thus, there was no evidence of in- 
teraction. 
The N-terminal peptide was much less soluble than 
that from the C-terminus but 1OOpM solutions that 
gave satisfactory signals were obtained in 0.5 mM 
DTT, 10 mM sodium bicarbonate, pH 7.0. Peptide 
l-32 appeared to be aggregated in solution as judged 
by the extensively broad appearance of the signals, par- 
ticularly those due to hydrophobic residues (Fig. 1). 
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Fig. 1. ‘H-NMR spectral effects of the binding of F-acthr to dystrophin residues 1-32. (A) Dystro~~n peptide, 160 CM, in DzO solution. Note 
the very broad lineshapes of the peptide resonances hown on an expanded scale (32 x). (B) Addition of 8 FM F-actin causes an apparent increase 
in signal intensity (cf. the signal of the standard denoted by a *) resulting from a decrease in resonance lime width. (Cc) In the presence of 16 FM 
F-actin, the resonances of, e.g. Tyr-11 and Thr-20,22 are now readily resolved. 
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Fig. 2. ‘H-NMR spectral titration of dystrophin residues 10-32 with F-actin. (A) 200 CM dystrophin peptide. (B) and (C) upon addition of 8 /cM 
and 16 FM F-actin. respectively (cf. Fig. 1). (D) Spectrum of the stock solution of F-actin titrated into the peptide. (A-C) Difference spectrum 
resolving signals of the peptide perturbed by complex formation with F-actin. The resonance ~signm~ts shown were obtained by analysis of 
the COSY spectrum (Fig. 3). 
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The signal intensities did not correspond well to the 
composition since the majority did not integrate pro- 
perly indicating multimeric aggregates. 
On the addition to peptide l-32 of F-actin up to 
16pM, at which concentration actin does not con- 
tribute significantly to the spectrum, marked changes in 
the peptide spectrum occurred progressively as the actin 
concentration increased (Fig. 1). The signal intensities 
due to the CHg of valine and leucine, the y-CHs of 
threonine and those due to aromatic residues increased. 
This implies that disaggregation of the peptide has oc- 
curred, given the observed increase in mobility now 
available to these groups. Addition of actin also led to 
some precipitate formation. The observations sug- 
gested that actin interacts with peptide l-32 with an af- 
finity constant > 104, given the concentrations used, 
but the interpretation of the NMR spectra is com- 
plicated by the disaggregation of the peptide as a conse- 
quence of the interaction. 
The signals from tryptophan and tyrosine residues 
that are concentrated in the N-terminal part of peptide 
l-32 were broadened in the absence of actin, whereas 
those arising from phenylalanine in the C-terminal part 
were not. This suggests that the aggregation involved in 
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Fig. 3. ‘H homonuclear correlated contour plot of the dystrophin peptide, residues 10-32, showing the chemical shift positions of through-bond 
correlated resonances. The resonances identified in Fig. 2 are boxed. Peptide concentration 3OO/tM, pH 7.2, T = 300 K. The spectrum was 
obtained with 400 increments each of size ZK with 64 transients for each value of tl and a relaxation delay of 1 s. After acquisition, the data 
were multiplied by a sine-bell function and the 2-dimensional transform processed to a final size of 2K by 2K. 
161 
Volume 263, number 1 FEBS LETTERS 
Dys trophin 
f 
Peptide lo-32 
A 
I 
&’ & & & &I 4 & & & & 
MLWUEEVEDCYEREDVQKlKTFTtKWVNAQFSKF 
1 I I 32 
Chicken Smooth YgKqoR;KTFT\AUCNSH 
April 1990 
I I 
Chicken Skeletal UEKOQRlKTFT(AWCNSE 
I 
Dictyostelium 
: 
WEITOK,KTFT,AWLNSli 
I I 
Fig. 4. N-terminal sequences of human dystrophin and the cr-actinins. Brackets indicate N-terminal peptides used in NMR studies. Sequences from 
Blanchard et al. [S]. Residues of the dystrophin N-terminal sequence that are perturbed on interaction with F-actin are indicated by arrows. 
particular the N-terminal region of the peptide. An ad- 
ditional peptide corresponding to residues lo-32 of 
dystrophin was synthesized and examined in the expec- 
tation that aggregation would be minimized and 
facilitate the interpretation of the effects with actin. 
Fig. 2 shows that well-resolved signals occur for all the 
residues, indicating that peptide lo-32 is not ag- 
gregated. The coupling patterns readily discernible for 
the various proton resonances enabled us to go on to 
examine the peptide spectrum by two-dimensional cor- 
related spectroscopy (Fig. 3) to derive the assignments 
shown in Fig. 2. 
Addition of F-actin to peptide lo-32 indicated that 
selective broadening of the specific signals, e.g. due to 
phenylalanine, occurred progressively during titration. 
The differential perturbation of the various peptide 
group signals is apparent from the difference spectra 
shown in Fig. 2. This indicates that the resonances of 
the ,&CH3 of alanine 27, the y-CH3 of threonines 20 
and 22, the e-CH2 of lysine and the y-CH3 of one of the 
two valines but not of tyrosine were perturbed by the 
addition of F-actin. Similar results were obtained with 
three different actin preparations. In the absence of ag- 
gregation of peptide 10-32, it can be concluded that 
changes in signals observed reflect specific interactions 
of actin with the peptide. In view of the absence of 
evidence for interaction with the C-terminal dystrophin 
peptide and our experience of the validity of ex- 
trapolating the results obtained with peptides to the 
whole molecule from which they were derived [4,5], we 
conclude that the region represented by residues lo-32 
in the intact dystrophin molecule encompasses a site of 
interaction with actin. 
When putative actin-binding domains of four dif- 
ferent cz-actinins and human dystrophin are aligned 
(Fig. 4) the residues at positions 19-22 in the latter pro- 
tein, namely Lys-Thr-Phe-Thr, are identical in all five 
proteins [7]. We believe that it is highly significant that 
the NMR studies indicate that these residues are per- 
turbed when actin interacts with peptide 10-32. 
162 
Although these investigations indicate that residues 
19-22 together with associated residues are involved in 
interaction with actin, we are unable to say yet whether 
this is the only site of interaction between these two 
proteins. It might be presumed that these residues are 
also involved in the interactions of the cu-actinins with 
F-actin. In view of the basic nature of this actin contact 
segment of dystrophin and hence its similarity to the ac- 
tin contact regions of both troponin I and caldesmon 
[4,5], it is plausible that binding occurs at or close to 
the acidic N-terminal residues of actin. 
Work is in progress to determine whether other 
regions of the dystrophin molecule are involved in in- 
teraction with actin and to define regions of the actin 
amino acid sequence that are concerned. 
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